OMNIPAQUE 210 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Omnipaque 210, and what generic alternatives are available?
Omnipaque 210 is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in OMNIPAQUE 210 is iohexol. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iohexol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OMNIPAQUE 210?
- What are the global sales for OMNIPAQUE 210?
- What is Average Wholesale Price for OMNIPAQUE 210?
Summary for OMNIPAQUE 210
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 25 |
Patent Applications: | 3,513 |
DailyMed Link: | OMNIPAQUE 210 at DailyMed |
Recent Clinical Trials for OMNIPAQUE 210
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal | Phase 4 |
Claire Bourgeois | Phase 4 |
Fédération des médecins résidents du Québec | Phase 4 |
Pharmacology for OMNIPAQUE 210
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for OMNIPAQUE 210
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | OMNIPAQUE 210 | iohexol | INJECTABLE;INJECTION | 018956-006 | Jun 30, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for OMNIPAQUE 210
See the table below for patents covering OMNIPAQUE 210 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1132901 | AGENT DE CONTRASTAGE AUX RAYONS X A BASE D'ANILINE ET TAMPON DONT LE PH S'ABAISSE AVEC LA TEMPERATURE (ANILINE X-RAY AGENT AND BUFFER WHOSE PH DECREASES WITH TEMPERATURE) | ⤷ Sign Up |
South Africa | 7903313 | ⤷ Sign Up | |
Philippines | 10017 | NOVEL IODINATED X-RAY CONTRAST AGENTS | ⤷ Sign Up |
Israel | 34803 | ⤷ Sign Up | |
Portugal | 69869 | ⤷ Sign Up | |
Sweden | 7706792 | ⤷ Sign Up | |
Japan | S5531068 | MANUFACTURE OF X RAY CONTRAST AGENT INJECTABLE STERILIZED SOLUTION | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |